Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Bisphosphonate therapy can cause jawbone necrosis, so dental care is crucial before and during treatment.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Botulinum toxin A injections reduce scalp oil for up to 3 months.

Abrocitinib may effectively treat Lichen Planopilaris.

The Foxn1(-/-) phenotype disrupts hair growth and affects skin stem cells.

A calcified nodule on a boy's face came from hair follicles and expelled calcium through the skin.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Different tissues in cows have different types of cytokeratins.

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

An addax had skin cancer that spread to lymph nodes and was euthanized.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Fine needle aspiration with rapid on-site evaluation is useful for diagnosing pilomatrixoma.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Targeting the PIEZO1 and MLCK axis may offer a new treatment for hair loss.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.